Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | IBOImpact Biomedical Inc.FY2025 · Dec |
|---|---|
| Revenue | $32.00K |
| Revenue, yoy | −36.0% |
| Net income | $11.84M |
| Net income, yoy | +52.1% |
| Net margin | -36,993.8% |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $0.38 |
Add another company.